279 related articles for article (PubMed ID: 25170077)
21. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
[TBL] [Abstract][Full Text] [Related]
22. The deubiquitinating enzyme USP8 promotes trafficking and degradation of the chemokine receptor 4 at the sorting endosome.
Berlin I; Higginbotham KM; Dise RS; Sierra MI; Nash PD
J Biol Chem; 2010 Nov; 285(48):37895-908. PubMed ID: 20876529
[TBL] [Abstract][Full Text] [Related]
23. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide.
Hsu LC; Ali SR; McGillivray S; Tseng PH; Mariathasan S; Humke EW; Eckmann L; Powell JJ; Nizet V; Dixit VM; Karin M
Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7803-8. PubMed ID: 18511561
[TBL] [Abstract][Full Text] [Related]
24. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
[TBL] [Abstract][Full Text] [Related]
25. A short isoform of NOD2/CARD15, NOD2-S, is an endogenous inhibitor of NOD2/receptor-interacting protein kinase 2-induced signaling pathways.
Rosenstiel P; Huse K; Till A; Hampe J; Hellmig S; Sina C; Billmann S; von Kampen O; Waetzig GH; Platzer M; Seegert D; Schreiber S
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3280-5. PubMed ID: 16492792
[TBL] [Abstract][Full Text] [Related]
26. IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.
Scotti E; Calamai M; Goulbourne CN; Zhang L; Hong C; Lin RR; Choi J; Pilch PF; Fong LG; Zou P; Ting AY; Pavone FS; Young SG; Tontonoz P
Mol Cell Biol; 2013 Apr; 33(8):1503-14. PubMed ID: 23382078
[TBL] [Abstract][Full Text] [Related]
27. Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage.
Tan G; Zeng B; Zhi FC
Eur J Cell Biol; 2015 Jan; 94(1):60-6. PubMed ID: 25433720
[TBL] [Abstract][Full Text] [Related]
28. Reciprocal cross-regulation between RNF41 and USP8 controls cytokine receptor sorting and processing.
De Ceuninck L; Wauman J; Masschaele D; Peelman F; Tavernier J
J Cell Sci; 2013 Aug; 126(Pt 16):3770-81. PubMed ID: 23750007
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages.
Takahashi Y; Isuzugawa K; Murase Y; Imai M; Yamamoto S; Iizuka M; Akira S; Bahr GM; Momotani E; Hori M; Ozaki H; Imakawa K
J Vet Med Sci; 2006 May; 68(5):471-8. PubMed ID: 16757890
[TBL] [Abstract][Full Text] [Related]
30. Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.
Negroni A; Stronati L; Pierdomenico M; Tirindelli D; Di Nardo G; Mancini V; Maiella G; Cucchiara S
Inflamm Bowel Dis; 2009 Aug; 15(8):1145-54. PubMed ID: 19266573
[TBL] [Abstract][Full Text] [Related]
31. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis.
Homer CR; Richmond AL; Rebert NA; Achkar JP; McDonald C
Gastroenterology; 2010 Nov; 139(5):1630-41, 1641.e1-2. PubMed ID: 20637199
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
[TBL] [Abstract][Full Text] [Related]
33. The intermediate filament protein, vimentin, is a regulator of NOD2 activity.
Stevens C; Henderson P; Nimmo ER; Soares DC; Dogan B; Simpson KW; Barrett JC; ; Wilson DC; Satsangi J
Gut; 2013 May; 62(5):695-707. PubMed ID: 22684479
[TBL] [Abstract][Full Text] [Related]
34. Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages.
Hedl M; Abraham C
J Biol Chem; 2011 Jul; 286(30):26440-9. PubMed ID: 21659536
[TBL] [Abstract][Full Text] [Related]
35. Organic dust augments nucleotide-binding oligomerization domain expression via an NF-{kappa}B pathway to negatively regulate inflammatory responses.
Poole JA; Kielian T; Wyatt TA; Gleason AM; Stone J; Palm K; West WW; Romberger DJ
Am J Physiol Lung Cell Mol Physiol; 2011 Sep; 301(3):L296-306. PubMed ID: 21665963
[TBL] [Abstract][Full Text] [Related]
36. NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists.
Kvarnhammar AM; Petterson T; Cardell LO
Immunology; 2011 Nov; 134(3):314-25. PubMed ID: 21978001
[TBL] [Abstract][Full Text] [Related]
37. A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses.
Marinis JM; Homer CR; McDonald C; Abbott DW
J Biol Chem; 2011 Jan; 286(3):1938-50. PubMed ID: 21097508
[TBL] [Abstract][Full Text] [Related]
38. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
Yao Q
Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
[TBL] [Abstract][Full Text] [Related]
39. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease.
Wang TT; Dabbas B; Laperriere D; Bitton AJ; Soualhine H; Tavera-Mendoza LE; Dionne S; Servant MJ; Bitton A; Seidman EG; Mader S; Behr MA; White JH
J Biol Chem; 2010 Jan; 285(4):2227-31. PubMed ID: 19948723
[TBL] [Abstract][Full Text] [Related]
40. The protein ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an autophagy-independent manner.
Sorbara MT; Ellison LK; Ramjeet M; Travassos LH; Jones NL; Girardin SE; Philpott DJ
Immunity; 2013 Nov; 39(5):858-73. PubMed ID: 24238340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
